Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-19

FDA Approved: AUVI-Q — Supplemental Application (kaleo, Inc)

View source ↗

Summary

FDA approved a supplemental application for AUVI-Q (epinephrine) submitted by Kaleo, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AUVI-Q (Epinephrine)

Snippet

SUPPL AP for AUVI-Q (EPINEPHRINE)